Fatty liver disease (MASLD/MASH) trials in Malaysia

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  Where

  Ampang, Kota Bharu, Kuala Lumpur, Putrajaya

  Age

  18 years and over

  People

  1,800 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT06632444 · EU 2024-513739-25-00
• Phase 3Taking people
  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  Where

  Ampang, Kota Bharu, Kuala Lumpur, Putrajaya

  Age

  18 years and over

  People

  1,590 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT06632457 · EU 2024-513741-36-00
• Phase 2Not yet taking people in Malaysia
  The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFLD)

  Where

  Cheras

  Age

  18 years to 65 years

  People

  26

  Run by

  Universiti Kebangsaan Malaysia Medical Centre

  See details and how to joinNCT07466485